ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Potassium Phosphate, Tribasic → tert-butyl 4-(2-(7-(N-(4-methoxybenzyl)-N-(thiazol-2-yl)sulfamoyl)-2H-benzo[b][1,4]oxazin-4(3 H)-yl)-5-(trifluoromethyl)phenyl)-5,6-dihydropyridine-1(2 H)-carboxylate

HRID 528541
印刷

反応式

HRID 528541 の反応式
Cl[C:2]1[CH:7]=[C:6]([C:8]([F:11])([F:10])[F:9])[CH:5]=[CH:4][C:3]=1[N:12]1[CH2:17][CH2:16][O:15][C:14]2[CH:18]=[C:19]([S:22]([N:25]([CH2:31][C:32]3[CH:37]=[CH:36][C:35]([O:38][CH3:39])=[CH:34][CH:33]=3)[C:26]3[S:27][CH:28]=[CH:29][N:30]=3)(=[O:24])=[O:23])[CH:20]=[CH:21][C:13]1=2.B1([C:49]2[CH2:54][CH2:53][N:52]([C:55]([O:57][C:58]([CH3:61])([CH3:60])[CH3:59])=[O:56])[CH2:51][CH:50]=2)OC(C)(C)C(C)(C)O1.P([O-])([O-])([O-])=O.[K+].[K+].[K+]>C(C1C(C(C)(C)C)=C([Pd]Cl)C=CC=1NC)(C)(C)C>[CH3:39][O:38][C:35]1[CH:34]=[CH:33][C:32]([CH2:31][N:25]([C:26]2[S:27][CH:28]=[CH:29][N:30]=2)[S:22]([C:19]2[CH:20]=[CH:21][C:13]3[N:12]([C:3]4[CH:4]=[CH:5][C:6]([C:8]([F:11])([F:9])[F:10])=[CH:7][C:2]=4[C:49]4[CH2:54][CH2:53][N:52]([C:55]([O:57][C:58]([CH3:61])([CH3:60])[CH3:59])=[O:56])[CH2:51][CH:50]=4)[CH2:17][CH2:16][O:15][C:14]=3[CH:18]=2)(=[O:23])=[O:24])=[CH:37][CH:36]=1
参加物反応条件実験手順後処理出典と根拠反応ノート

参加物

5

反応物 3

HCID 62657Potassium Phosphate, TribasicHCID 4642098Tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine-1-carboxylateHCID 897617974-(2-chloro-4-(trifluoromethyl)phenyl)-N-(4-methoxybenzyl)-N-(thiazol-2-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazine-7-sulfonamide2 回

生成物 1

HCID 89761906
tert-butyl 4-(2-(7-(N-(4-methoxybenzyl)-N-(thiazol-2-yl)sulfamoyl)-2H-benzo[b][1,4]oxazin-4(3 H)-yl)-5-(trifluoromethyl)phenyl)-5,6-dihydropyridine-1(2 H)-carboxylate

試薬・触媒・溶媒 1

HCID 178482226HCID 178482226、化合物触媒

反応条件

温度
112 °C

実験手順

A 5-mL glass microwave reaction vessel was charged with 4-(2-chloro-4-(trifluoromethyl)phenyl)-N-(4-methoxybenzyl)-N-(thiazol-2-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazine-7-sulfonamide (INTERMEDIATE X, 0.150 g, 0.252 mmol), (n-tert-butoxycarbonyl)-1,2,3,6-tetrahydropyridine-4-boronic acid pinacol ester (0.195 mL, 0.629 mmol), 1,1-bis[(di-t-butyl-p-methylaminophenyl]palladium(II) chloride (0.027 g, 0.038 mmol), and potassium phosphate (0.083 mL, 1.007 mmol). The vessel was sealed and flushed with N2. Dioxane (1 mL) and water (0.32 mL) were added via syringe and the mixture was sparged with N2 for 5 min. The reaction mixture was stirred and heated in a microwave reactor at 112° C. for 3 h. After cooling to rt, the reaction was diluted with EtOAc and the organic layer was decanted from aqueous layer at the bottom of the vial. The organic layer was concentrated and absorbed onto a 5 g loading cartridge and passed through a silica gel column (12 g) using a gradient from 0% to 60% EtOAc in Heptanes to provide tert-butyl 4-(2-(7-(N-(4-methoxybenzyl)-N-(thiazol-2-yl)sulfamoyl)-2H-benzo[b][1,4]oxazin-4(3 H)-yl)-5-(trifluoromethyl)phenyl)-5,6-dihydropyridine-1(2 H)-carboxylate. This product was dissolved in DCM (5 mL) and the solution was cooled to 0° C. Trifluoroacetic acid (1 mL) was added dropwise to generate a bright pink solution. The cold bath was removed and the solution was stirred for 30 min. Additional trifluoroacetic acid (1 mL) was added dropwise and the solution was maintained at rt for 5 min. The solution was partitioned between ice/brine and DCM. The layers were separated and the aqueous layer was extracted with DCM (3×). The combined organic layers were dried (Na2SO4) and concentrated. The resulting residue was dissolved in MeOH/DMSO and purified by reverse-phase preparative HPLC using 0.1% TFA in CH3CN/H2O, gradient 10% to 80% over 15 min to provide 4-(2-(1,2,3,6-tetrahydropyridin-4-yl)-4-(trifluoromethyl)phenyl)-N-(thiazol-2-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazine-7-sulfonamide 2,2,2-trifluoroacetate (0.075 g, 0.118 mmol) as a white solid. 1H NMR (500 MHz, DMSO-d6) δ ppm 3.20 (br. s., 4 H) 3.52-3.62 (m, 2 H) 3.69 (br. s., 2 H) 4.28 (br. s., 2 H) 5.89 (br. s., 1 H) 6.48 (d, J=8.55 Hz, 1 H) 6.79 (d, J=4.59 Hz, 1 H) 7.08-7.26 (m, 3 H) 7.53-7.66 (m, 2 H) 7.70-7.80 (m, 1 H) 8.67-8.87 (m, 2 H) 12.46-12.62 (m, 1 H).

後処理

  1. customThe vessel was sealed
  2. customflushed with N2
  3. additionDioxane (1 mL) and water (0.32 mL) were added via syringe
  4. customthe mixture was sparged with N2 for 5 min
  5. temperatureAfter cooling to rt
  6. additionthe reaction was diluted with EtOAc
  7. customthe organic layer was decanted from aqueous layer at the bottom of the vial
  8. concentrationThe organic layer was concentrated
  9. customabsorbed onto a 5 g loading cartridge

出典と根拠

ORDレコード
ord-86a71460cee64f6c91e30855d4d5ee32
出典データセット
uspto-grants-2016_05
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US09346798B2

反応ノート

このページの内容参加物反応条件実験手順後処理出典と根拠反応ノート